Inflation-Adjusted Beneficiary Coinsurance Adjustment and Adjusted Medicare Payment for Part B Rebatable Drugs With Price Increases Faster Than Inflation ( 427.200 Through 427.201) Section 1847A(i)(5) of the Act requires that for Part B rebatable drugs, as defined in section 1847A(i)(2)(A) of the Act, furnished on or after April 1, 2023, in quarters in which the payment amount described in section 1847A(i)(3)(A)(ii)(I) of the Act (or, in the case of selected drugs described under section 1192(c) of the Act, the payment amount described in section 1847A(b)(1)(B) of the Act), exceeds the inflation-adjusted payment amount determined in accordance with section 1847A(i)(3)(C) of the Act, the coinsurance will be 20 percent of the inflation-adjusted payment amount for such quarter (hereafter, the inflation-adjusted coinsurance amount)

Related articles Making an IMPACT on consumers and society: Working together against illegal trade Watch as the Expert Council members of PMI IMPACT discuss how to combat illegal trade and its impact on consumers, communities, and governments
Stories of travelers facing pressure at customs when it comes to electronics arent unheard of, with accounts of demands for fees and threats of device confiscation for those who haven't declared everything correctly
Rai PK, Lee SS, Zhang M, Tsang YF, Kim KH (2019) Heavy metals in food crops: health risks, fate, mechanisms, and management